New Zealand markets open in 5 hours 43 minutes
  • NZX 50

    11,847.15
    +58.12 (+0.49%)
     
  • NZD/USD

    0.6334
    -0.0033 (-0.52%)
     
  • ALL ORDS

    7,361.90
    +37.00 (+0.51%)
     
  • OIL

    86.78
    -2.63 (-2.94%)
     
  • GOLD

    1,787.90
    -10.20 (-0.57%)
     

3 Things About Moderna That Smart Investors Know

·4-min read

Prior to the pandemic, Moderna (NASDAQ: MRNA) was like many other small biotechs. In fact, for the full year of 2019, Moderna had only $60 million in revenue, entirely from collaborations and grants, and it posted a net loss of $514 million. As we know, Moderna's ability to rapidly produce a vaccine for the COVID-19 virus changed the financial prospects for the company and put it in a completely different position today.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting